Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial report ‘should ring alarm bells’
The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states.
Data shows growing resistance to salmonella and campylobacter 

Antimicrobials used to treat diseases that are transmitted between animals and humans are becoming less effective, according to a report by the European Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).

EU Commissioner for health and food safety, Vytenis Andriukaitis, said: “The report released today should ring – again – alarm bells. It shows that we are entering into a world where more and more common infections become difficult – or even sometimes impossible – to treat."

The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states. It found that resistance to fluoroquinolones is so high in Campylobacter in some countries that they no longer work for the treatment of severe cases.

Most countries reported that Salmonella in humans is becoming increasingly resistant to fluoroquinolones. Multidrug resistance is high in Salmonella found in humans (28.3%) and animals, particularly in S. Typhimurium.

Mike Catchpole, ECDC’s chief scientist, said. “Now is the time to turn the tide on antimicrobial resistance, if we want to keep antibiotics working. It’s particularly worrying when it comes to combined resistance: even low proportions mean that many thousands of patients across the EU have limited treatment options for severe infections.”

Marta Hugas, EFSA’s chief scientist, said: “We have seen that when Member States have implemented stringent policies, antimicrobial resistance has decreased in animals. Annual reporting by European and national agencies includes noteworthy examples. This should serve as an inspiration for other countries.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.